KDM3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.209200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.938000E-01
Normal-vs-Stage2
9.872000E-01
Normal-vs-Stage3
1.255210E-01
Normal-vs-Stage4
8.509800E-01
Stage1-vs-Stage2
4.630000E-01
Stage1-vs-Stage3
3.081600E-01
Stage1-vs-Stage4
3.966600E-01
Stage2-vs-Stage3
1.317950E-01
Stage2-vs-Stage4
8.917200E-01
Stage3-vs-Stage4
1.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.044400E-01
Normal-vs-AfricanAmerican
7.796800E-01
Normal-vs-Asian
9.372000E-01
Caucasian-vs-AfricanAmerican
8.887200E-01
Caucasian-vs-Asian
6.794400E-01
AfricanAmerican-vs-Asian
7.455200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.772800E-01
Normal-vs-Female
8.382400E-01
Male-vs-Female
5.508200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.105800E-01
Normal-vs-Age(41-60Yrs)
5.874600E-01
Normal-vs-Age(61-80Yrs)
6.565000E-01
Normal-vs-Age(81-100Yrs)
7.748600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.603000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.658200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.368800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.414100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.200600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.007000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.736400E-01
Normal-vs-Daily Drinker
6.038200E-01
Normal-vs-Weekly Drinker
2.733800E-01
Normal-vs-Occasional Drinker
4.728400E-01
Normal-vs-Social Drinker
9.803800E-01
Non Drinker-vs-Daily Drinker
5.415000E-01
Non Drinker-vs-Weekly Drinker
1.505050E-01
Non Drinker-vs-Occasional Drinker
6.377900E-02
Non Drinker-vs-Social Drinker
7.168600E-01
Daily Drinker-vs-Weekly Drinker
3.081400E-01
Daily Drinker-vs-Occasional Drinker
2.034500E-02
Daily Drinker-vs-Social Drinker
2.977200E-01
Weekly Drinker-vs-Occasional Drinker
7.822100E-03
Weekly Drinker-vs-Social Drinker
4.676100E-02
Occasional Drinker-vs-Social Drinker
1.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.726360E-02
Normal-vs-Grade 2
6.459200E-03
Normal-vs-Grade 3
3.839400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.519900E-03
Grade 1-vs-Grade 3
2.036800E-03
Grade 1-vs-Grade 4
1.726360E-02
Grade 2-vs-Grade 3
5.018200E-01
Grade 2-vs-Grade 4
6.459200E-03
Grade 3-vs-Grade 4
3.839400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.844600E-01
Normal-vs-NonDiabetic
9.828600E-01
Diabetic-vs-NonDiabetic
4.369800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.577000E-01
Normal-vs-NoPancreatitis
8.289600E-01
Pancreatitis-vs-NoPancreatitis
1.004640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.542800E-01
Normal-vs-N1
9.973400E-01
N0-vs-N1
3.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.886610E-01
Normal-vs-TP53-NonMutant
5.634200E-01
TP53-Mutant-vs-TP53-NonMutant
4.593900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
